
    
      The changes in eligibility criteria indicated below are from a previously approved amendment
      but were inadvertently omitted in the previous PRS update made in November of 2020.
      Therefore, this note serves to clarify the order of updates.

      Inclusion: HbA1c â‰¥ 7.5% in the last 2 months (modification)

      Exclusion:

        -  More than 1 slow-acting injection and unwilling to switch to once a day for the study
           (addition)

        -  Severe hypoglycemic episode within one month of admission (addition)
    
  